Ondansetron as a Supportive Therapeutic Agent for Severe Pruritus in Pediatric Patients with Chronic Cholestasis

被引：0
|
作者：
El-koofy, Nehal M. [1 ]
Elmonem, Mohamed A. [2 ]
El-Mahdy, Mai [1 ]
Okasha, Sawsan [1 ]
Enayet, Afaf [1 ]
机构：
[1] Cairo Univ, Fac Med, Dept Pediat, Cairo, Egypt
[2] Cairo Univ, Fac Med, Dept Clin & Chem Pathol, Cairo, Egypt
来源：
INDIAN JOURNAL OF PEDIATRICS | 2024年 / 91卷 / 01期
关键词：
D O I：
10.1007/s12098-023-04755-x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] Ondansetron as a Supportive Therapeutic Agent for Severe Pruritus in Pediatric Patients with Chronic Cholestasis
    Nehal M. El-koofy
    Mohamed A. Elmonem
    Mai El-Mahdy
    Sawsan Okasha
    Afaf Enayet
    Indian Journal of Pediatrics, 2024, 91 : 92 - 92
  • [2] Ondansetron for pruritus in child with chronic cholestasis
    Trioche, P
    Samuel, D
    Odievre, M
    Labrune, P
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (11) : 990 - 990
  • [3] Use of rifampin for severe pruritus in children with chronic cholestasis
    Yerushalmi, B
    Sokol, RJ
    Narkewicz, MR
    Smith, D
    Karrer, FM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1999, 29 (04): : 442 - 447
  • [4] Ondansetron for refractory pruritus of cholestasis. Evidence in favor of therapeutic intervention on nociception.
    Milano, MC
    Gutierrez, S
    Wainstein, R
    Colombato, LA
    GASTROENTEROLOGY, 1997, 112 (04) : A1333 - A1333
  • [5] A multivariate Analysis of the Therapeutic Goals of Patients with chronic Pruritus
    Steinke, S.
    Bruland, P.
    Blome, C.
    Osada, N.
    Zeidler, C.
    Augustin, M.
    Staender, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 185 - 186
  • [6] The influence of itch: Quality of life in pediatric patients with chronic pruritus
    Seamens, Alexandra
    Greskovich, Caitlin
    Lee, Grace
    Roberts, James
    Chen, Suephy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB218 - AB218
  • [7] Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients
    Narita, I
    Alchi, B
    Omori, K
    Sato, F
    Ajiro, J
    Saga, D
    Kondo, D
    Skatsume, M
    Maruyama, S
    Kazama, JJ
    Akazawa, K
    Gejyo, F
    KIDNEY INTERNATIONAL, 2006, 69 (09) : 1626 - 1632
  • [8] Increased eosinophils as a biomarker for therapeutic response in patients with chronic pruritus of unknown origin
    Khanna, R.
    Patel, S. P.
    Williams, K.
    Kwatra, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S120 - S120
  • [9] THERAPEUTIC VALUE OF A CARDIOPROTECTIVE AGENT IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY
    BROTTIER, L
    BARAT, JL
    COMBE, C
    BOUSSENS, B
    BONNET, J
    BRICAUD, H
    EUROPEAN HEART JOURNAL, 1990, 11 (03) : 207 - 212
  • [10] Use of colesevelam hydrochloride (welchol™) as a novel therapeutic agent for the management of refractory pruritus in chronic liver disease.
    Berg, CL
    HEPATOLOGY, 2001, 34 (04) : 541A - 541A
12345